Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice

BACKGROUND: The capacity of the recombinant Vaccinia virus GLV-1h68 as a single agent to efficiently treat different human or canine cancers has been shown in several preclinical studies. Currently, its human safety and efficacy are investigated in phase I/II clinical trials. In this study we set ou...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hofmann, Elisabeth, Weibel, Stephanie, Szalay, Aladar A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4105246/
https://ncbi.nlm.nih.gov/pubmed/25030093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-197
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak